Loading...
Market
Will CVS Caremark face additional legal actions from other states by December 31, 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Public legal filings and news reports
Story
CVS Caremark to Pay $45 Million Settlement to Illinois Over Drug Rebates via Subsidiary Zinc
Jul 24, 2024, 10:39 AM
CVS Caremark has agreed to pay at least $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to the state during a recent four-year period. The settlement follows an investigation by the Illinois Attorney General, which found that CVS Caremark, through its subsidiary Zinc, inappropriately pocketed drug rebates using a rebate aggregator. This settlement is expected to add to the increasing scrutiny of pharmacy benefit managers (PBMs) and their role in the pharmaceutical pricing system.
View original story
Similar markets
Yes • 50%
No • 50%
Announce internal policy changes • 25%
Face additional lawsuits • 25%
No significant actions taken • 25%
Announce new partnerships or acquisitions • 25%
CVS Caremark • 25%
OptumRx • 25%
Prime Therapeutics • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
